Urgent

Apnoea of prematurity

Recurrent apnoea in the preterm · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Apnoea of prematurity is pauses in breathing >20 seconds (or shorter with bradycardia or desaturation) due to immature respiratory control, and is a diagnosis of exclusion once secondary causes have been ruled out. It is common below 34 weeks and usually resolves by term-corrected age.

Red flags

  • New-onset apnoea in a previously stable or term infant (suggests sepsis/serious pathology)
  • Apnoea with seizure-like movements
  • Apnoea accompanied by abdominal signs (NEC)
  • Profound or prolonged bradycardia/desaturation needing PPV
  • Sudden increase in frequency or severity of events

Assessment

Differential diagnosis

  • Sepsis/meningitis
  • Hypoxaemia from lung disease or anaemia
  • Hypoglycaemia or electrolyte disturbance (Na, Ca, Mg)
  • Intracranial pathology (IVH) or seizures
  • Gastro-oesophageal reflux or feeding-related apnoea
  • Temperature instability, patent ductus arteriosus, or NEC

Investigations

  • Continuous cardiorespiratory and SpO2 monitoring with event recording
  • Full blood count, CRP and blood culture if infection suspected
  • Blood glucose, electrolytes, calcium and magnesium
  • Blood gas
  • Cranial ultrasound if neurological cause suspected
  • Consider echocardiography for PDA if clinically indicated

Management

  • Place on continuous apnoea/bradycardia and oxygen-saturation monitoring.
  • During an episode, provide gentle tactile stimulation first.
  • If no response, deliver positive-pressure ventilation via mask with supplemental oxygen as needed and restore breathing.
  • Ensure airway positioning (neutral, avoid neck flexion) and check for secretions.
  • Exclude secondary causes with the investigations above before attributing events to prematurity.
  • Start a methylxanthine (caffeine) as first-line pharmacological treatment.
  • Consider nasal CPAP or high-flow for frequent obstructive or mixed apnoeas.
  • Maintain a neutral thermal environment and avoid overheating.
  • Optimise haemoglobin and treat anaemia; address reflux pragmatically (positioning, feed management).
  • Treat any identified PDA, sepsis or metabolic abnormality.
  • Document frequency and severity of events to guide escalation and weaning.
  • Ensure a documented apnoea-free period before discharge and arrange home monitoring only if clinically indicated.

Drugs & doses

Caffeine citrate 20 mg/kg IV/PO loading then 5–10 mg/kg once daily maintenance (titrate up to 10 mg/kg/dose for persistent apnoea)
Aminophylline 6–8 mg/kg IV loading then 2–2.5 mg/kg every 8–12 h (second-line, with levels)
Doxapram 0.5–2.5 mg/kg/hour IV infusion (specialist use for refractory apnoea on a monitored unit)

Disposition

Neonatal unit with continuous monitoring; step down as events resolve; ensure an event-free interval and corrected-age appropriate stability before discharge, with clear safety-netting.

Complications & pitfalls

  • Hypoxic injury from recurrent desaturation
  • Need for intubation/ventilation
  • Delayed discharge
  • Masking of an underlying serious illness
  • Feeding difficulty and failure to thrive

Exam pearls

  • Apnoea of prematurity is a diagnosis of exclusion – rule out sepsis first, especially for new or worsening events.
  • Caffeine is first-line, has a wide therapeutic margin and also reduces BPD and need for PDA treatment.
  • Mixed/obstructive apnoea often responds to CPAP.
  • Events typically resolve by 37–44 weeks corrected age.
  • A sudden surge in apnoeas warrants a full sepsis and NEC assessment.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.